HIF1A and nasal cavity polyp: Despite limited clinical data, it has been demonstrated in ex vivo models of tissues in patients with chronic rhinosinusitis with nasal polyps that wogonin supplementation would reduce the expression of HIF‐1 and survivin, suggesting that it may be applicable in the regulation of tumor‐like growth hormone‐mediated proliferation on inflamed tissue.